The Patent Finder

EMD Lexigen Research Center Corp.

Also on record
Records under this name other than patents EMD Lexigen Research Center Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to EMD Lexigen Research Center Corp.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,767,405Immunocytokine Sequences and Uses Thereof
Formerly held
Term ended
Term ended Nov 30, 2025 · High confidence
Term endedTerm ended Nov 30, 2025High confidence
US 8,420,087INTERLEUKIN-12 Targeted to Oncofoetal Fibronectin
Formerly held
Lapsed on the fee record
Ended Apr 16, 2025 · High confidence
Lapsed on the fee recordEnded Apr 16, 2025High confidence
US 7,186,804IL-2 Fusion Proteins with Modulated Selectivity
Formerly held
Term ended
Term ended Jan 20, 2025 · High confidence
Term endedTerm ended Jan 20, 2025High confidence
US 7,323,549IL-7 Fusion Proteins
Formerly held
Term ended
Term ended Dec 30, 2024 · High confidence
Term endedTerm ended Dec 30, 2024High confidence
US 8,338,575IL-7 Fusion Proteins
Formerly held
Lapsed on the fee record
Ended Dec 25, 2024 · High confidence
Lapsed on the fee recordEnded Dec 25, 2024High confidence
US 8,470,991Immunocytokine Sequences and Uses Thereof
Formerly held
Term ended
Term ended May 21, 2024 · High confidence
Term endedTerm ended May 21, 2024High confidence
US 7,169,904Immunocytokine Sequences and Uses Thereof
Formerly held
Term ended
Term ended Dec 16, 2023 · High confidence
Term endedTerm ended Dec 16, 2023High confidence
US 7,960,514IL-7 Fusion Proteins
Formerly held
Lapsed on the fee record
Ended Jun 14, 2023 · Medium confidence
Lapsed on the fee recordEnded Jun 14, 2023Medium confidence
US 7,888,071DNA Encoding IL-2 Fusion Proteins with Modulated Selectivity
Formerly held
Lapsed on the fee record
Ended Feb 15, 2023 · Medium confidence
Lapsed on the fee recordEnded Feb 15, 2023Medium confidence
US 6,992,174Reducing the Immunogenicity of Fusion Proteins
Formerly held
Term ended
Term ended Jan 28, 2023 · High confidence
Term endedTerm ended Jan 28, 2023High confidence
10 of 43 patents shown.
Pro members see all 43.
Pro members: see all 43 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited